Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew S Miller

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Journal of Medical Virology|October 12, 2023
Early humoral and cellular responses after bivalent SARS-CoV-2 mRNA-1273.214 vaccination in long-term care and retirement home residents in Ontario, Canada: An observational cohort studyJessica A Breznik, Ahmad Rahim, Hina Bhakta, et al.
Viruses|April 30, 2021
Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 SubjectsAngela Huynh, Donald M Arnold, James W Smith, et al.
Nature Communications|October 12, 2017
Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in miceWenqian He, Chi-Jene Chen, Caitlin E Mullarkey, et al.
Angewandte Chemie (International Ed. in English)|August 31, 2021
High-Affinity Dimeric Aptamers Enable the Rapid Electrochemical Detection of Wild-Type and B.1.1.7 SARS-CoV-2 in Unprocessed SalivaZijie Zhang, Richa Pandey, Jiuxing Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2014
Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humansAli H Ellebedy, Florian Krammer, Gui-Mei Li, et al.
ERJ Open Research|June 10, 2025
AeroVax: study protocol for a randomised, double-blind, placebo-controlled, phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humansAdam S Komorowski, Lawrence Mbuagbaw, Mangalakumari Jeyanathan, et al.
Journal of the American Chemical Society|December 15, 2022
Three on Three: Universal and High-Affinity Molecular Recognition of the Symmetric Homotrimeric Spike Protein of SARS-CoV-2 with a Symmetric Homotrimeric AptamerJiuxing Li, Zijie Zhang, Jimmy Gu, et al.
Plos Pathogens|June 29, 2023
Targeting the MR1-MAIT cell axis improves vaccine efficacy and affords protection against viral pathogensRasheduzzaman Rashu, Marina Ninkov, Christine M Wardell, et al.
The FEBS Journal|November 19, 2016
Regulation of kynurenine biosynthesis during influenza virus infectionLana Gaelings, Sandra Söderholm, Andrii Bugai, et al.
Nature Immunology|March 31, 2015
Senataxin suppresses the antiviral transcriptional response and controls viral biogenesisMatthew S Miller, Alexander Rialdi, Jessica Sook Yuin Ho, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Journal of Medical Virology|October 12, 2023
Early humoral and cellular responses after bivalent SARS-CoV-2 mRNA-1273.214 vaccination in long-term care and retirement home residents in Ontario, Canada: An observational cohort studyJessica A Breznik, Ahmad Rahim, Hina Bhakta, et al.
Viruses|April 30, 2021
Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 SubjectsAngela Huynh, Donald M Arnold, James W Smith, et al.
Nature Communications|October 12, 2017
Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in miceWenqian He, Chi-Jene Chen, Caitlin E Mullarkey, et al.
Angewandte Chemie (International Ed. in English)|August 31, 2021
High-Affinity Dimeric Aptamers Enable the Rapid Electrochemical Detection of Wild-Type and B.1.1.7 SARS-CoV-2 in Unprocessed SalivaZijie Zhang, Richa Pandey, Jiuxing Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2014
Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humansAli H Ellebedy, Florian Krammer, Gui-Mei Li, et al.
ERJ Open Research|June 10, 2025
AeroVax: study protocol for a randomised, double-blind, placebo-controlled, phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humansAdam S Komorowski, Lawrence Mbuagbaw, Mangalakumari Jeyanathan, et al.
Journal of the American Chemical Society|December 15, 2022
Three on Three: Universal and High-Affinity Molecular Recognition of the Symmetric Homotrimeric Spike Protein of SARS-CoV-2 with a Symmetric Homotrimeric AptamerJiuxing Li, Zijie Zhang, Jimmy Gu, et al.
Plos Pathogens|June 29, 2023
Targeting the MR1-MAIT cell axis improves vaccine efficacy and affords protection against viral pathogensRasheduzzaman Rashu, Marina Ninkov, Christine M Wardell, et al.
The FEBS Journal|November 19, 2016
Regulation of kynurenine biosynthesis during influenza virus infectionLana Gaelings, Sandra Söderholm, Andrii Bugai, et al.
Nature Immunology|March 31, 2015
Senataxin suppresses the antiviral transcriptional response and controls viral biogenesisMatthew S Miller, Alexander Rialdi, Jessica Sook Yuin Ho, et al.
Pageof 12